Tech Company Financing Transactions

VenoStent Funding Round

VenoStent, based in Nashville, secured $20 million from Good Growth Capital, IAG Capital Partners and private investors.

Transaction Overview

Company Name
Announced On
6/27/2024
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors

Good Growth Capital (Lead Investor)

IAG Capital Partners (Lead Investor)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Advanced Materials
Mailing Address
1710 Linden Ave.
Nashville, TN 37212
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
VenoStent, Inc. is an early stage medical device and biomaterial platform company company developing a shape memory polymer wrap to help hemodialysis patients live longer, less painful, and more prosperous lives.
Profile
VenoStent LinkedIn Company Profile
Social Media
VenoStent Company Twitter Account
Company News
VenoStent News
Facebook
VenoStent on Facebook
YouTube
VenoStent on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Boire
  Timothy Boire LinkedIn Profile  Timothy Boire Twitter Account  Timothy Boire News  Timothy Boire on Facebook
Chief Operating Officer
Geoff Lucks
  Geoff Lucks LinkedIn Profile  Geoff Lucks Twitter Account  Geoff Lucks News  Geoff Lucks on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/27/2024: gaiia venture capital transaction
Next: 6/27/2024: Ovation venture capital transaction

 

Share this article

 


News on VC Transactions

We document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary